GlobalRPh Renal Dosing Masterv6.6
Source review / handoff

Bumetanide - BUMEX oral tablets

One or two intact local summaries. No averaged regimen, patient-specific dose or automatic source preference.

Return to full drug recordAll source differencesRead selected sourcesHow to use this review

Selecting here opens the current stored cards. The pinned link below records their fingerprints. Do not enter patient information in links or searches.

Share or print this source review

1 local source card selected. Local card fingerprints checked where supplied. This is not an original-document hash, source-currency guarantee or clinical approval. Record-level cautions below are the current library's cautions, not a frozen prior version.

Copy is optional; the link can be selected and copied manually. No patient data or dose decision is collected.

Clinical context remains essential

Independent clinical review is pending. Confirm indication, exact formulation/route, population, renal measure and units, kidney-function stability, dialysis prescription, interacting drugs, monitoring and source revision. An RX mirror and its original label are not independent corroboration. Missing disagreement notes do not certify agreement.

Check source scope before reading a dose

GlobalRPh RX List - BUMEX oral tablets

Product / population
Adult oral bumetanide; selected renal precautions, not IV/neonatal dosing.
Renal method
Response, urine output and laboratory trend; no CrCl dosing ladder
Source revision
1/2024
Retrieved
2026-09-10
Local review status
Selected source sections stored locally. Not a complete monograph or independent clinical approval.

Documented differences and cautions on this drug

All record notes are retained here, including notes about sources not selected in this review.

Before use: Bumetanide - BUMEX oral tablets

Anuria and progressive renal deterioration require action; absence of a CrCl ladder is not no-adjustment evidence.

What to reconcile: Confirm the exact product, indication, renal measure and full source before prescribing.

Source-specific interpretation; independent clinician adjudication pending.

Open this note and its source references
Rxlist

GlobalRPh RX List - BUMEX oral tablets

Open original reference

GlobalRPh-hosted RX List · Adult oral bumetanide; selected renal precautions, not IV/neonatal dosing.

Renal method: Response, urine output and laboratory trend; no CrCl dosing ladder
Source date: 1/2024
Retrieved: 2026-09-10

Label mirror, not independent corroboration. This is selected locally stored RX List content. Full monograph import and current official-label review are not implied.
Restriction or avoidance guidance. Read the specific threshold, age, formulation and dialysis exclusions; do not generalize across products.
Before using this finding

Confirm the exact product, indication, renal measure and full source before prescribing.

Dialysis evidence: No dialysis regimen established in selected content

Selected source sections stored locally. Not a complete monograph or independent clinical approval.

Renal guidance and important limits

Limits that apply to these rows

Individualize oral dosing and monitor diuresis, volume and electrolytes. Severe depletion is a contraindication until corrected.

Marked water/electrolyte losses and ototoxicity risk require attention; do not infer a dialysis replacement schedule from use in renal edema.

No new official-label card was obtained for this product in v6.3. Earlier source layers, if present, were retained but not rechecked.

BUMEX renal contraindication and stop criteria
Clinical findingSource-specific dose / instruction
AnuriaContraindicated
Progressive renal disease with marked BUN/creatinine increase or oliguriaSource directs discontinuation
Read the retained text before reformatting

BUMEX renal contraindication and stop criteria

Clinical findingSource-specific dose / instruction
AnuriaContraindicated
Progressive renal disease with marked BUN/creatinine increase or oliguriaSource directs discontinuation

Individualize oral dosing and monitor diuresis, volume and electrolytes. Severe depletion is a contraindication until corrected.

Marked water/electrolyte losses and ototoxicity risk require attention; do not infer a dialysis replacement schedule from use in renal edema.

RDM63-rxlist-bumetanide-9522369540-C1 · Source locator: Contraindications; volume/electrolyte and renal warnings

Source-specific limits

Individualize oral dosing and monitor diuresis, volume and electrolytes. Severe depletion is a contraindication until corrected.

Marked water/electrolyte losses and ototoxicity risk require attention; do not infer a dialysis replacement schedule from use in renal edema.

No new official-label card was obtained for this product in v6.3. Earlier source layers, if present, were retained but not rechecked.

Source identity and provenance
Source family
product_label_mirror
Source
https://globalrph.com/rx-list/bumex-drug/
Retrieved
2026-09-10
Renal-function method
Response, urine output and laboratory trend; no CrCl dosing ladder
Source date/version
1/2024
Hash meaning
Local authored summary, not source HTML/XML/PDF bytes
Local summary SHA-256
5184dfc44c6b89a5a9c631a485fc938a30e5ccd988becec69b42db0052560aa6

Document the clinical decision separately

This reference does not select a regimen. Complete the indication, measured/estimated renal function and trend, dialysis setting, source rationale, monitoring and reassessment plan in your institution's approved documentation system. Confirm the complete current source before adopting its regimen.

GlobalRPh v6.6 | RDM66-DIRECT-PHP-20260911 | Local library date 2026-09-11. Selected-card identity does not imply clinical verification.

Pinned reference: https://globalrph.com/blogCalcs/renal-dosing-master/compare.php?id=bumetanide&s1=RDM63-rxlist-bumetanide-9522369540&h1=592e4a94d5aee9d015a439130ca1113bad492496814400f1d00da1a442d1c0e9